The Clinton Health Access Initiative, Inc. (CHAI) is a global health organization committed to saving lives and reducing the burden of disease in low-and middle-income countries, while strengthening the capabilities of governments and the private sector in those countries to create and sustain high-quality health systems that can succeed without our assistance. For more information, please visit: http://www.clintonhealthaccess.org.
Overview of CHAI's Vaccines program
Immunization is one of the most successful public health interventions in history. National immunization programs reach >100 million infants every year and have averted globally two to three million deaths every year since the launch of the Expanded Program for Immunization (EPI) in 1974 , whilst the pneumococcal conjugate vaccine (PCV) and rotavirus vaccines could save ~1 million lives per year. Furthermore, great advances in discovering and financing new vaccines provides a great opportunity for countries to further reduce burden of disease such as human papillomavirus (HPV). Despite these successes, 1.5 million children still die each year of vaccine-preventable diseases, many of them in low-income countries, as immunization programs there face unprecedented challenges.
Since 2010, the Clinton Health Access Initiative (CHAI) has worked to save lives and reduce the burden from vaccine preventable diseases by improving access to immunization services in resource-limited setting by strengthening national immunization programs and by leveraging its experience in-country to improve the global immunization ecosystem. CHAI is pursuing six complementary strategic goals:
CHAI's vaccine program very closely supports the national immunization programs in 11 focus countries - Cameroon, Ethiopia, India, Indonesia, Kenya, Lao PDR, Lesotho, Nigeria, Tanzania, Uganda and Vietnam- and also engages with global stakeholders such as Gavi, WHO and UNICEF to inform global policies and practices.
Immunization Service Delivery
Despite significant gains made in immunization coverage from 21% in 1980, global DTP3 coverage has stalled at approximately 85% since 2010, while DTP3 coverage in Africa has stagnated at 76% as of 2015. As a result, nearly one quarter of children under-5 in the region are under- or unimmunized. Immunization coverage is generally much lower for vaccines that are delivered via weaker or complex delivery platforms, such as maternal, neonatal, 9-month, second year and adolescent - whether current vaccines or those slated for introduction. For example, only 28% of African countries have maintained 90% measles conjugate vaccine / measles rubella vaccine first dose (MCV1/MR1) coverage since 2013.
CHAI therefore will develop, test, and scale innovative service delivery interventions in focus countries, with the objective to increase coverage in priority populations in a way that can be scaled and sustained by governments. CHAI will support governments to (i) improve the planning and the performance management of immunization sessions; (ii) improve the linkages of maternal and newborn health services with immunization to increase routine immunization coverage and strengthen the neonatal platform used for OPV, BCG, and HepB birth dose; (iii) increase the routine coverage of the nine-month platform (when vaccines against measles, yellow fever, meningitis A or Typhoid should be administered); and (iv) develop better informed coverage plans and support the implementation of key service delivery strategies to target unimmunized children. CHAI will distill the tools and lessons learned from this work in focus countries and disseminate them to the global community.
We are seeking an Associate or Senior Associate to join the Global Vaccines Delivery team and support CHAI's work in improving coverage and equity through new vaccine introductions and enhancing service delivery across focus countries.
We are seeking a motivated and mission-oriented individual with strong analytic, problem-solving, and cross-cultural communication skills. The candidate should be experienced at presenting data and messages powerfully through written documents and presentations; working collaboratively in a fast-paced, multi-cultural environment; and functioning independently with minimal guidance.
This role will be based in a CHAI program country in the region, pending country team leadership approval.
 CDC. Global Routine Vaccination Coverage, 2016. https://www.cdc.gov/mmwr/volumes/66/wr/pdfs/mm6645a3-H.PDF
 Since 2011, the uptake of impactful new vaccines, including Pentavalent, PCV and Rotavirus, has significantly progressed, enabled by financial support from Gavi and partners. However, these vaccines relied upon the most effective delivery platform in most countries, one that reaches children between the second to fourth month of life.
 Please see Appendix 4: Acronyms for guidance with acronyms and abbreviations
 Measles elimination in the WHO African Region: Progress and challenges, 2015
1) Provide strategic and programmatic support for the design and implementation of in-country work to improve immunization coverage and equity in a sustainable manner
2) Inform national and global practices and policies related to immunization service delivery
3) Support the development of CHAI's vaccines program, in collaboration with program and country leadership
4) Support program and grant management, in collaboration with program and country leadership